PNC Financial Services Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-584
| Closed | -$88K | – | 4946 |
|
|
2022
Q3 | $88K | Buy |
584
+104
| +22% | +$15.7K | ﹤0.01% | 2631 |
|
|
2022
Q2 | $71K | Sell |
480
-255
| -35% | -$37.7K | ﹤0.01% | 2791 |
|
|
2022
Q1 | $88K | Sell |
735
-232
| -24% | -$27.8K | ﹤0.01% | 2791 |
|
|
2021
Q4 | $133K | Buy |
967
+159
| +20% | +$21.9K | ﹤0.01% | 2500 |
|
|
2021
Q3 | $112K | Buy |
808
+72
| +10% | +$9.98K | ﹤0.01% | 2576 |
|
|
2021
Q2 | $71K | Sell |
736
-109
| -13% | -$10.5K | ﹤0.01% | 2859 |
|
|
2021
Q1 | $57K | Sell |
845
-831
| -50% | -$56.1K | ﹤0.01% | 2910 |
|
|
2020
Q4 | $144K | Sell |
1,676
-65
| -4% | -$5.59K | ﹤0.01% | 2278 |
|
|
2020
Q3 | $114K | Buy |
1,741
+26
| +2% | +$1.7K | ﹤0.01% | 2249 |
|
|
2020
Q2 | $124K | Buy |
1,715
+1,688
| +6,252% | +$122K | ﹤0.01% | 2206 |
|
|
2020
Q1 | $1K | Buy |
+27
| New | +$1K | ﹤0.01% | 3867 |
|
|
2019
Q4 | – | Sell |
-86
| Closed | -$4K | – | 4259 |
|
|
2019
Q3 | $4K | Sell |
86
-13
| -13% | -$605 | ﹤0.01% | 3796 |
|
|
2019
Q2 | $5K | Buy |
+99
| New | +$5K | ﹤0.01% | 3763 |
|
|
2018
Q2 | – | Sell |
-26
| Closed | – | – | 4481 |
|
|
2018
Q1 | $0 | Hold |
26
| – | – | ﹤0.01% | 4443 |
|
|
2017
Q4 | $0 | Buy |
26
+2
| +8% | – | ﹤0.01% | 4422 |
|
|
2017
Q3 | $1K | Sell |
24
-16
| -40% | -$667 | ﹤0.01% | 4121 |
|
|
2017
Q2 | $1K | Buy |
+40
| New | +$1K | ﹤0.01% | 4142 |
|